Aprogenex appoints David Leech acting CEO; Leech also elected to board of directors.HOUSTON--(BUSINESS WIRE)--April 3, 1996--Aprogenex Inc. (ASE (Adaptive Server Enterprise) A relational DBMS from Sybase that runs on Windows NT/2000, Linux and a variety of Unix platforms. ASE is a comprehensive and robust data management product with a long history dating back to the late 1980s. :APG APG Assists Per Game (basketball) APG Assists Per Game (hockey statistic) APG Aberdeen Proving Ground APG Automated Password Generator APG Asia Pacific Group on Money Laundering ), a developer of next-generation diagnostic tests based upon its proprietary DNA probe technology that greatly improves the ability to analyze intact cells at a molecular level, Wednesday announced the appointment of David Leech as acting president and chief executive officer and as a member of the board of directors. ``The addition of David Leech to the board and as acting CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. provides excellent leadership to the management team at Aprogenex,'' stated Terry Ward, chairman of the board of the company. ``David's prior experience both as the CEO of public biotechnology companies as well as his background in pharmaceutical marketing, business collaborations and fund raising should serve us well as we move forward with our HIV HIV (Human Immunodeficiency Virus), either of two closely related retroviruses that invade T-helper lymphocytes and are responsible for AIDS. There are two types of HIV: HIV-1 and HIV-2. HIV-1 is responsible for the vast majority of AIDS in the United States. program and seek broader collaborations in genetics.'' Leech previously served as president and CEO of Argus Pharmaceuticals from 1992 to 1995, and was president and CEO of Houston Biotechnology Inc. from 1988 to 1992. He previously served in various senior marketing and management positions with American Cyanamid and Sterling Drug. Leech is a resident of Houston. The other members of the board of directors are Ward, the chief financial officer of W.S. Farish & Co., which is a substantial shareholder of the company; Joel Bresser, the co-founder of the company; and Donald Payne, the CFO See Chief Financial Officer. of the company. Aprogenex develops, manufactures and markets DNA DNA: see nucleic acid. DNA or deoxyribonucleic acid One of two types of nucleic acid (the other is RNA); a complex organic compound found in all living cells and many viruses. It is the chemical substance of genes. probe-based test systems based on its proprietary RIGHTechnology, which is broadly applicable to extensive markets in genetics, oncology, virology virology, study of viruses and their role in disease. Many viruses, such as animal RNA viruses and viruses that infect bacteria, or bacteriophages, have become useful laboratory tools in genetic studies and in work on the cellular metabolic control of gene expression and microbiology. The company is currently developing or marketing research products for HIV viral load HIV viral load AIDS A measure of the amount of HIV RNA in blood, expressed as number of copies/mL of plasma. See AIDS, HIV. and detection of genetic disorders. The statements in this news release that are not historical facts are forward-looking statements and are subject to a wide range of risks and uncertainties, including but not limited to risks and uncertainties relating to product development activities; new or developing markets; limited marketing experience; need for additional financing; government regulation; licenses, patents and trade secrets; potential adverse effects of technological change and competition; dependence on key personnel; possibility of product liability claims; and other factors detailed in the company's Securities and Exchange Commission filings. CONTACT: Aprogenex Inc., Houston J. Donald Payne, 713/748-5114 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion